Fortis Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Fortis Capital Advisors's RGEN Position: Q2 2024 in Review
Fortis Capital Advisors sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,782 shares — an estimated $328K sold.
Fortis Capital Advisors first reported a position in RGEN in Q4 2022 and held it in 3 quarters. The position peaked at $328K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.
- Fortis Capital Advisors reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
- Fortis Capital Advisors sold 1,782 Repligen shares in Q2 2024, an estimated $328K.
- Fortis Capital Advisors first reported a position in Repligen in Q4 2022 and held it in 3 quarters.
- Fortis Capital Advisors's Repligen position peaked at $328K in Q1 2024.
- 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.
Based on Fortis Capital Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.